Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood acute lymphocytic leukemia.

W A Smithson, G S Gilchrist, E O Burgert

    CA: a Cancer Journal for Clinicians
    |May 1, 1980
    PubMed
    Summary

    Most children with acute lymphoblastic leukemia (ALL) now survive long-term without major issues. Specialized care and risk assessment are crucial for optimal outcomes and early detection of side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mayo clinic tumor rounds.

    Orthopedics·2014
    Same author

    Aspects of Carbohydrate Metabolism in Kwashiorkor.

    British medical journal·2010
    Same author

    An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer.

    European journal of oncology nursing : the official journal of European Oncology Nursing Society·2003
    Same author

    Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.

    Haemophilia : the official journal of the World Federation of Hemophilia·2002
    Same author

    Haemorrhage into a popliteal cyst: an unusual complication of haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2002
    Same author

    Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

    Leukemia·2002

    Area of Science:

    • Pediatric Oncology
    • Hematology

    Background:

    • Significant advancements in treating childhood acute lymphoblastic leukemia (ALL) have led to improved long-term survival rates.
    • Many children treated for ALL now experience prolonged survival without severe long-term complications.

    Purpose of the Study:

    • To emphasize the importance of experienced medical supervision for all children undergoing ALL treatment.
    • To highlight the necessity of risk stratification and tailored treatment approaches for high-risk pediatric cancer patients.

    Main Methods:

    • This study is a review of current pediatric ALL treatment protocols and outcomes.
    • It emphasizes clinical assessment of risk factors and the implementation of innovative treatment strategies.
    • Long-term patient follow-up protocols are discussed.

    Main Results:

    • Children with ALL treated under expert supervision demonstrate prolonged survival.
    • Risk assessment allows for targeted interventions in high-risk populations.
    • Early identification of treatment toxicity is achievable through diligent follow-up.

    Conclusions:

    • All children with acute lymphoblastic leukemia benefit from treatment by experienced pediatric oncologists.
    • Personalized treatment plans based on risk assessment and innovative programs improve outcomes.
    • Continuous long-term follow-up is vital for managing potential treatment toxicities effectively.

    Related Experiment Videos